To discuss editorial submissions,
contact Taren Grom, Editor, at
Published monthly, with combined July/August and November/December issues, PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic and multifaceted life-sciences industry.
PharmaVOICE reaches more than 27,000 BPA-qualified subscribers with every issue. PharmaVOICE’s unique horizontal editorial approach cuts across industry silos, provides a holistic overview of the life-sciences industry, and addresses a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialogue, initiates debate, and opens the lines of communications to facilitate and improve business-to-business relationships. PharmaVOICE’s unique and in-depth original forums, feature articles, executive bios, and departments are people-focused and audience-driven.
PharmaVOICE provides executives with useful peer-to-peer insights on a broad range of business practices and topics from clinical research through commercialization.